Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 0 0 1 1 1 5 15 36
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 1 48 0 7 51 135
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 1 4 15 1 7 21 37
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 0 5 1 8 18 32
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 1 48 1 4 25 199
Estimating Lifetime or Episode-of-illness Costs 0 1 2 110 1 2 12 297
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 0 0 5 159
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 6 8 18 116
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 0 5 12 202
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 1 47 1 3 13 173
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 1 1 1 291 2 6 13 885
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 0 16 1 4 9 30
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 0 86 1 5 19 175
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 1 6 8 45
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 1 63 2 5 20 114
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 1 1 51 0 6 13 47
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 1 5 30 80
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 1 3 11 239
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 1 3 12 114
The Role of Physician Altruism in the Physician-Industry Relationship 0 0 2 12 1 6 15 30
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 0 1 6 107
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 0 1 9 171
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 0 3 12 62
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 54 1 5 11 229
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 2 2 3 486 3 7 18 1,360
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 1 147 1 4 14 534
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 1 2 9 64
Total Working Papers 3 6 19 1,883 29 121 419 5,672


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 0 1 6 30
Comparing alternative models: log vs Cox proportional hazard? 0 0 0 148 0 4 11 581
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 0 2 12 327
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 0 2 10 52
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 0 3 14 259
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 2 7 53
Estimating lifetime or episode‐of‐illness costs under censoring 0 0 2 23 1 4 21 102
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 0 145 0 2 7 427
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 0 143 1 4 8 366
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 1 8 32
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 0 105 0 4 16 304
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 0 3 18 202
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 1 15
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 1 40 1 2 7 159
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 0 0 8 110
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 0 2 7 54
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 2 12 16 34
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 1 1 53 0 3 7 224
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 2 7 15 290
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 4 6 16 939 8 25 99 2,802
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 0 2 9 43
Total Journal Articles 4 7 20 1,784 15 85 307 6,466


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 1 28 0 7 21 259
Total Software Items 0 0 1 28 0 7 21 259


Statistics updated 2026-06-04